GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxcell-Bio Therapeutics (XKRX:323990) » Definitions » Margin of Safety % (DCF Earnings Based)

Vaxcell-Bio Therapeutics (XKRX:323990) Margin of Safety % (DCF Earnings Based) : N/A (As of May. 15, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Vaxcell-Bio Therapeutics Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Vaxcell-Bio Therapeutics's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.


Competitive Comparison of Vaxcell-Bio Therapeutics's Margin of Safety % (DCF Earnings Based)

For the Biotechnology subindustry, Vaxcell-Bio Therapeutics's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaxcell-Bio Therapeutics's Margin of Safety % (DCF Earnings Based) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vaxcell-Bio Therapeutics's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Vaxcell-Bio Therapeutics's Margin of Safety % (DCF Earnings Based) falls into.


;
;

Vaxcell-Bio Therapeutics Margin of Safety % (DCF Earnings Based) Related Terms

Thank you for viewing the detailed overview of Vaxcell-Bio Therapeutics's Margin of Safety % (DCF Earnings Based) provided by GuruFocus.com. Please click on the following links to see related term pages.


Vaxcell-Bio Therapeutics Business Description

Industry
Traded in Other Exchanges
N/A
Address
12-55, Sandan-gil, Hwasun-eup, Hwasun-gun, Jeollanam-do, Yeosu, KOR, 58141
Vaxcell-Bio Therapeutics is a bio-technology company engaged in the development of Cell-based and Protein-based Immunotherapeutics for the treatment of cancer.

Vaxcell-Bio Therapeutics Headlines

No Headlines